These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20483057)

  • 1. Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Laghi Pasini F; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(2):290-1. PubMed ID: 20483057
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.
    Sakallioglu O; Duzova A; Ozen S
    Clin Exp Rheumatol; 2006; 24(4):435-7. PubMed ID: 16956436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with infliximab of a patient with tumor necrosis factor-associated periodic syndrome (TRAPS) who failed to respond to etanercept.
    Krelenbaum M; Chaiton A
    J Rheumatol; 2010 Aug; 37(8):1780-2. PubMed ID: 20675856
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful etanercept treatment of constrictive pericarditis complicating rheumatoid arthritis.
    Aslangul E; Perrot S; Durand E; Mousseaux E; Le Jeunne C; Capron L
    Rheumatology (Oxford); 2005 Dec; 44(12):1581-3. PubMed ID: 16204377
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
    Rudwaleit M; Sieper J
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1882-6. PubMed ID: 16118732
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.
    Drewe E; McDermott EM; Powell RJ
    N Engl J Med; 2000 Oct; 343(14):1044-5. PubMed ID: 11023397
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of etanercept to control extra-articular manifestations of rheumatoid arthritis.
    Hall SJ; Hickling P
    J Clin Rheumatol; 2007 Feb; 13(1):54. PubMed ID: 17278957
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept treatment in Sweet's syndrome with inflammatory arthritis.
    Ambrose NL; Tobin AM; Howard D
    J Rheumatol; 2009 Jun; 36(6):1348-9. PubMed ID: 19509095
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept.
    Esposito M; Giunta A; Babino G; Schipani C; Marchei M; Chimenti MS
    Eur J Dermatol; 2012; 22(1):151-2. PubMed ID: 22155373
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital myositis in a rheumatoid arthritis patient during etanercept treatment.
    Caramaschi P; Biasi D; Carletto A; Bambara LM
    Clin Exp Rheumatol; 2003; 21(1):136-7. PubMed ID: 12673906
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.
    Minden K; Aganna E; McDermott MF; Zink A
    Ann Rheum Dis; 2004 Oct; 63(10):1356-7. PubMed ID: 15361406
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.
    Topaloğlu R; Ayaz NA; Waterham HR; Yüce A; Gumruk F; Sanal O
    Clin Rheumatol; 2008 Oct; 27(10):1317-20. PubMed ID: 18506569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
    Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
    Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of familial Mediterranean fever and juvenile idiopathic arthritis with osteoporosis successfully treated with etanercept.
    Kaya S; Kaptanoglu E; Elden H; Hizmetli S
    Intern Med; 2010; 49(6):619-22. PubMed ID: 20228604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color and duplex Doppler sonography to detect sacroiliitis and spinal inflammation in ankylosing spondylitis. Can this method reveal response to anti-tumor necrosis factor therapy?
    Unlü E; Pamuk ON; Cakir N
    J Rheumatol; 2007 Jan; 34(1):110-6. PubMed ID: 17216679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept-associated right abducens nerve palsy in rheumatoid arthritis.
    Lai CC; Hsiao KH; Chang YS; Tsai CY; Chou CT
    Int J Rheum Dis; 2012 Oct; 15(5):e117-9. PubMed ID: 23083045
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
    Aróstegui JI; Solís P; Aldea A; Cantero T; Rius J; Bahíllo P; Plaza S; Vives J; Gómez S; Yagüe J
    Eur J Pediatr; 2005 Jan; 164(1):13-6. PubMed ID: 15549379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.